# US 2019/0169229 A1 · Tangential flow filtration based protein refolding methods

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0169229 A1
- Document ID: US20190169229A1
- Status: Published application
- Kind: A1
- Application number: 16/211,094
- Filed: 2018-12-05
- Published: 2019-06-06
- Earliest claimed: 2013-02-12
- Assignees: Bristol-Myers Squibb Company
- Applicants: Bristol-Myers Squibb Company
- Inventors: Benjamin C. BLUM; Cristopher HOLLANDER
- Web page: https://patentgrep.com/patent/US20190169229A1

## CPC

- C07K 1/1136: {by reversible modification of the secondary, tertiary or quarternary structure, e.g. using denaturating or stabilising agents}
- C07K 1/145: {by extraction or solubilisation}
- C07K 1/34: by filtration, ultrafiltration or reverse osmosis
- C07K 14/78: Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
- C07K 16/18: against material from animals or humans
- C07K 2317/14: Specific host cells or culture conditions, e.g. components, pH or temperature
- C07K 2317/52: Constant or Fc region; Isotype
- C07K 2319/30: Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

Provided herein are methods for refolding proteins that are denatured. Exemplary methods comprise solubilizing the denatured protein with a denaturing agent, e.g., a chaotropic agent, and renaturing the protein using a buffer exchanging system, e.g., tangential flow filtration (TFF).

## Claims

### Claim 1

A method for refolding a denatured protein, comprising
combining denatured protein with a solubilization buffer to obtain a first protein composition comprising solubilized denatured protein;
diafiltering the first protein composition comprising solubilized denatured protein with 2-4 diavolumes of a refold buffer, to obtain a second protein composition comprising partially refolded protein; and
incubating the second protein composition comprising partially refolded protein with a refold/oxidizing buffer to obtain a third protein composition comprising the protein in a refolded state.

### Claim 2

(canceled)

### Claim 3 (depends on 1)

The method of claim 1, wherein incubating the second protein composition comprising partially refolded protein with a refold/oxidizing buffer comprises diafiltering the second protein composition with 2-6 diavolumes of a refold/oxidizing buffer.

### Claim at position 4

4-9. (canceled)

### Claim 10 (depends on 1)

The method of claim 1, wherein diafiltering with refold buffer takes between 0.5 to 3 hours.

### Claim 11 (depends on 1)

The method of claim 1, wherein the diafiltering with refold/oxidizing buffer takes between 0.5 to 3 hours.

### Claim 12 (depends on 1)

The method of claim 1, wherein the refold buffer and the refold/oxidizing buffer have a pH value between pH 8 and 11.

### Claim at position 8

13-16. (canceled)

### Claim 17 (depends on 1)

The method of claim 1, wherein the refold buffer comprises Arginine.

### Claim 18 (depends on 1)

The method of claim 1, wherein the refold/oxidizing buffer comprises Arginine.

### Claim at position 11

19-26. (canceled)

### Claim 27 (depends on 1)

The method of claim 1, wherein the composition comprising solubilized denatured protein is not diluted prior to diafiltering.

### Claim 28 (depends on 1)

The method of claim 1, wherein the composition comprising solubilized denatured protein is filtered prior to diafiltering.

### Claim 29

(canceled)

### Claim 30 (depends on 1)

The method of claim 1, comprising
combining denatured protein with a solubilization buffer to obtain a first protein composition comprising solubilized denatured protein;
diafiltering the first protein composition comprising solubilized denatured protein with 2-4 diavolumes of a refold buffer to obtain a second protein composition comprising partially folded protein, wherein the refold buffer comprises Arginine and has a pH between pH 8-11; and
diafiltering the second protein composition comprising partially folded protein with 2-6 diavolumes of a refold/oxidizing buffer to obtain a third protein composition comprising the protein in a refolded state, wherein the refold/oxidizing buffer comprises Arginine, an oxidizing agent and has a pH between pH 8-11.

### Claim 31 (depends on 1)

The method of claim 1 for refolding a denatured protein, comprising
suspending the denatured protein in a suspension solution to obtain a composition comprising suspended denatured protein;
combining the composition comprising suspended denatured protein with a solubilization buffer to obtain a first protein composition comprising solubilized denatured protein;
diafiltering the first protein composition comprising solubilized denatured protein with 2-4 diavolumes of a refold buffer to obtain a second protein composition comprising partially refolded protein, wherein the refold buffer comprises Arginine and has a pH between pH 8-11; and
diafiltering the second protein composition comprising partially folded protein with 2-6 diavolumes of a refold/oxidizing buffer to obtain a third protein composition comprising the protein in a refolded state wherein the refold/oxidizing buffer comprises Arginine, an oxidizing agent and has a pH between pH 8-11.

### Claim at position 17

32-33. (canceled)

### Claim 34 (depends on 1)

The method of claim 1, wherein the third protein solution comprises 1-10 mg/ml of protein.

### Claim 35 (depends on 1)

The method of claim 1, wherein the efficiency of recovery is at least about 70%.

### Claim 36 (depends on 1)

The method of claim 1, wherein the protein comprises at least one disulfide bond.

### Claim at position 21

37-38. (canceled)

### Claim 39 (depends on 1)

The method of claim 1, wherein the protein comprises an Fc region.

### Claim at position 23

40-41. (canceled)

### Claim 42 (depends on 1)

The method of claim 1, wherein the protein comprises a binding domain that specifically binds to a target protein, wherein the binding domain is an alternative scaffold binding domain.

### Claim 43 (depends on 42)

The method of claim 42, wherein the alternative scaffold binding domain is an alternative fibronectin based scaffold domain.

### Claim 44 (depends on 43)

The method of claim 43, wherein the alternative fibronectin based scaffold domain is a 10FN3 domain.

### Claim 45

(canceled)

### Claim 46 (depends on 1)

The method of claim 1, wherein the solubilization buffer, refold buffer, and/or refold/oxidizing buffer comprises Tris.
